Toyomi Kamesaki Selected Research

Autoimmune Hemolytic Anemia (Cold Agglutinin Disease)

9/2020	Demographic characteristics, thromboembolism risk, and treatment patterns for patients with cold agglutinin disease in Japan.
1/2019	[Progress in diagnosis and treatment of autoimmune hemolytic anemia].
1/2019	Ectopic expression of band 3 anion transport protein in colorectal cancer revealed in an autoimmune hemolytic anemia patient.
1/2018	A Comprehensive Diagnostic Algorithm for Direct Antiglobulin Test-Negative Autoimmune Hemolytic Anemia Reveals the Relative Ratio of Three Mechanisms in a Single Laboratory.
7/2015	[Molecular mechanisms of autoimmune hemolytic anemia].
1/2015	Glucocorticoid-Responsive Cold Agglutinin Disease in a Patient with Rheumatoid Arthritis.
12/2013	Case of cytomegalovirus-associated direct anti-globulin test-negative autoimmune hemolytic anemia.
2/2013	Characterization of direct antiglobulin test-negative autoimmune hemolytic anemia: a study of 154 cases.
1/2013	Primary Sjögren syndrome presenting with hemolytic anemia and pure red cell aplasia following delivery due to Coombs-negative autoimmune hemolytic anemia and hemophagocytosis.
4/2011	Direct antiglobulin test-negative autoimmune hemolytic anemia associated with HLA-haploidentical stem cell transplantation.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Toyomi Kamesaki Research Topics

Disease

11	Autoimmune Hemolytic Anemia (Cold Agglutinin Disease) 09/2020 - 02/2009
5	Anemia 01/2021 - 02/2013
3	Hemolysis 01/2019 - 02/2013
2	Hemolytic Anemia 01/2022 - 01/2018
2	Colorectal Neoplasms (Colorectal Cancer) 05/2020 - 01/2019
1	Myocardial Infarction 09/2020
1	Neoplasms (Cancer) 07/2015
1	Immune System Diseases (Immune Disorders) 07/2015
1	Rheumatoid Arthritis 01/2015
1	Crohn Disease (Crohn's Disease) 12/2014
1	Evans Syndrome 02/2013
1	Pure Red-Cell Aplasia 01/2013
1	Aplastic Anemia (Anemia, Hypoplastic) 05/2010
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 05/2010
1	Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria) 05/2010
1	Bone Marrow Failure Disorders 05/2010
1	Inflammation (Inflammations) 12/2006
1	Choristoma (Ectopic Tissue) 11/2002

Drug/Important Bio-Agent (IBA)

6	Immunoglobulin G (IgG)IBA 01/2022 - 02/2009
3	SteroidsIBA 01/2021 - 02/2013
3	AutoantibodiesIBA 05/2020 - 07/2015
3	AntigensIBA 07/2015 - 11/2002
2	Complement System Proteins (Complement)IBA 09/2020 - 01/2015
2	AgglutininsIBA 01/2019 - 01/2015
2	Immunoglobulins (Immunoglobulin)IBA 01/2018 - 02/2013
2	HaptoglobinsIBA 01/2015 - 05/2010
1	TESIBA 09/2020
1	Erythrocyte Anion Exchange Protein 1 (Band 3 Protein)IBA 01/2019
1	Immunoglobulin M (IgM)IBA 01/2018
1	anti-IgAIBA 01/2018
1	anti-IgMIBA 01/2018
1	Immunoglobulin A (IgA)IBA 01/2018
1	Neoplasm Antigens (Tumor Antigens)IBA 07/2015
1	AntibodiesIBA 07/2015
1	Adalimumab (Humira)FDA Link 01/2015
1	Methotrexate (Mexate)FDA LinkGeneric 01/2015
1	GlucocorticoidsIBA 01/2015
1	GlobulinsIBA 12/2013
1	cytomegalovirus-specific hyperimmune globulinIBA 12/2013
1	SS-A antibodiesIBA 01/2013
1	Proteins (Proteins, Gene)FDA Link 12/2006
1	NF-kappa B (NF-kB)IBA 12/2006
1	CaspasesIBA 12/2006

Therapy/Procedure

1	Immunotherapy 07/2015
1	Therapeutics 12/2014
1	Stem Cell Transplantation 04/2011